The Resource for your Nonhuman Primate Research

We support innovation, reproducibility, and translation of preclinical research with high-quality biological development. We offer primate antibodies and recombinant proteins for pre-clinical NHP studies, NHP-specific reagents for in vitro assays, and have an industry wide antibody reactivity database for NHP species.

Recent Publications Using Our Reagents...

 

News and Announcements

 

Follow the lastest news on NHPRR's LinkedIn account  

 

Link to News Archives

https://www.nhpreagents.org/NewsUpdates

 

2024 December 20

Humoral correlates of protection against Mycobacterium tuberculosis following intravenous BCG vaccination in rhesus macaques.

Irvine, Edward B Darrah, Patricia A Wang, Shu Wang, Chuangqi McNamara, Ryan P Roederer, Mario Seder, Robert A Lauffenburger, Douglas A Flynn, JoAnne L Fortune, Sarah M Alter, Galit

iScience

Anti-rhesus IgG1 [ena]-HRP Anti-rhesus IgA [9B9]

2024 December 04

SHIV remission in macaques with early treatment initiation and ultra long-lasting antiviral activity.

Daly, Michele B Dinh, Chuong Holder, Angela Rudolph, Donna Ruone, Susan Swaims-Kohlmeier, Alison Khalil, George Sharma, Sunita Mitchell, James Condrey, Jillian Kim, Daniel Pan, Yi Curtis, Kelly Williams, Peter Spreen, William Heneine, Walid García-Lerma, J Gerardo

Nat Commun

Anti-CD8 alpha [MT807R1]

2024 November 01

A model of lymphocryptovirus-associated post-transplant lymphoproliferative disorder in immunosuppressed Mauritian cynomolgus macaques.

Wu, Helen L Weber, Whitney C Waytashek, Courtney M Boyle, Carla D Reed, Jason S Bateman, Katherine B Fisher, Hannah K Chen, Yan Armantrout, Kimberly Swanson, Tonya Shriver-Munsch, Christine Northrup, Mina Fischer, Miranda Biswas, Sreya Templon, John Panoskaltsis-Mortari, Angela Burwitz, Benjamin J Johnson, Amanda L Colgin, Lois Lewis, Anne D Smedley, Jeremy V Axthelm, Michael K Skalsky, Rebecca Meyers, Gabrielle Maziarz, Richard T Mittra, Erik Berg, Melissa Stanton, Jeffrey J Sacha, Jonah B

PLoS Pathog

Anti-CD8 beta [CD8b255R1] Anti-CD8 alpha [MT807R1] Anti-CD20 [2B8R1F8]-Afucosylated

2024 October 22

Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific response.

Rahman, Mohammad Arif Bissa, Massimiliano Scinto, Hanna Howe, Savannah E Sarkis, Sarkis Ma, Zhong-Min Gutowska, Anna Jiang, Xunqing Luo, Christina C Schifanella, Luca Moles, Ramona Silva de Castro, Isabela Basu, Shraddha N'guessan, Kombo F Williams, LaTonya D Becerra-Flores, Manuel Doster, Melvin N Hoang, Tanya Choo-Wosoba, Hyoyoung Woode, Emmanuel Sui, Yongjun Tomaras, Georgia D Paquin-Proulx, Dominic Rao, Mangala Talton, James D Kong, Xiang-Peng Zolla-Pazner, Susan Cardozo, Timothy Franchini, Genoveffa Berzofsky, Jay A

Nat Commun

Anti-alpha4/beta7 [A4B7R1]-APC

News & Updates:

2024 Aug 23

mAbsolve Parnership for Fc-silenced STR Antibodies

Today, we celebrate a milestone—partnering with mAbsolve to incorporate ‘STR’ mutations into our antibodies. This ensures targeted action without unintended immune responses, boosting rigor, effectiveness, and safety. By decreasing Fc-mediated interference (hello Fc-block!) and enhancing the signal-to-noise ratio, STR-enhanced antibodies will produce more robust and reproducible scientific findings. Expect many STR-enhanced antibodies soon!

READ MORE

2024 Apr 09

For your Acknowledgements section

Reagents used in these studies were provided by the NIH Nonhuman Primate Reagent Resource (P40 OD028116, U24 AI126683).

2024 Apr 11

NHPRR Linkedin

Follow our newest publications, products, and messages on LinkedIn!

READ MORE

2024 Apr 09

RRID Citation on Materials and Methods

For your Materials & Methods section: The rhesus recombinant Anti-CD8 beta [CD8b255R1] monoclonal antibody was engineered and produced by the Nonhuman Primate Reagent Resource (NIH Nonhuman Primate Reagent Resource Cat# PR-2557, RRID:AB_2716321)

Contribute to the Resource

Help Us By:

Sharing Your Data: Our community-based reactivity database is built by users like you. Share your results!

Requesting a Reagent: We develop NHP-specific antibodies based on investigator-initiated requests, including: recombinant proteins for cell depletion, receptor activation, cytokine neutralization, co-stimulatory blockade, immunosuppression.

Licensing Our Reagents: Interested in using our antibodies on your assays? Reach us!

Sharing Your Publication: If you’ve recently published a study using an NHPRR reagent, add it to the publication database.